“Inclisiran: Early LDL-C target achievement in a real-life population”
Background and objectives: Elevated low-density lipoprotein cholesterol (LDL-C) levels are associated with atherosclerotic cardiovascular diseases. Inclisiran, a small interfering RNA, has been observed to effectively and sustainably reduce LDL-C in large randomized controlled trials (RCTs); however...
Saved in:
Main Authors: | Francesco Briani, Mauro Bagli, Gabriele Venturi, Francesco Bacchion, Antonio Mugnolo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Atherosclerosis Plus |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S266708952500001X |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pathogenetic therapeutic approaches for endocrine diseases based on antisense oligonucleotides and RNA-interference
by: Olga Golounina, et al.
Published: (2025-01-01) -
Functions and applications of RNA interference and small regulatory RNAs
by: Feng Xuezhu, et al.
Published: (2024-11-01) -
Lipopolymers as the Basis of Non-Viral Delivery of Therapeutic siRNA Nanoparticles in a Leukemia (MOLM-13) Model
by: Panadda Yotsomnuk, et al.
Published: (2025-01-01) -
The biogenesis, regulation and functions of transitive siRNA in plants
by: Tan Huijun, et al.
Published: (2024-09-01) -
Long non-coding RNA involved in the carcinogenesis of human female cancer - a comprehensive review
by: Nazia Afroze, et al.
Published: (2025-02-01)